Edition:
United Kingdom

People: BTG PLC (BTG.L)

BTG.L on London Stock Exchange

834.00GBp
2:45pm BST
Change (% chg)

0.00 (+0.00%)
Prev Close
834.00
Open
836.00
Day's High
836.00
Day's Low
833.00
Volume
195,238
Avg. Vol
1,189,437
52-wk High
853.00
52-wk Low
467.40

O'Shea, W. James 

Mr. W. James O'Shea is Independent Non-Executive Director of BTG Plc, since April 2009. Jim serves as Chairman of Cardiome Pharma, is a director of Trevi Therapeutics, Inc., and Ocular Therapeutix™. Jim provides the Board with significant US industry experience. He is a former Chairman of the US National Pharmaceuticals Council. From 2007 to 2008, he was Vice Chairman of Sepracor, Inc., where he was also President and Chief Operating Officer from 1999 to 2007. Previously Jim was Senior Vice President of Sales & Marketing and Medical Affairs for Zeneca Pharmaceuticals (US), a business unit of Zeneca Inc. While at Zeneca, he held several management positions of increasing responsibility in international sales and marketing in the US and the UK.

Basic Compensation

Total Annual Compensation, GBP 54,000
Restricted Stock Award, GBP --
Long-Term Incentive Plans, GBP --
All Other, GBP 4,000
Fiscal Year Total, GBP 58,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --